-
Neuropsychiatric Disease and Treatment
-
About Dovepress
Open access peer-reviewed scientific and medical journals.
-
Open Access
Dove Medical Press is now a member of the Open Access Initiative
-
An Author's Guide
A guide to help authors get their paper published.
-
Advocacy
Support Open Access and Dove Press
-
Reprints
Promotional Article Monitoring - further details
-
Favored Author Program
Real benefits for authors, including fast-track processing of papers.
Beneficial effect of tibolone on mood, cognition, well-being, and sexuality in menopausal women
(2768) Views (654) Full article downloads
Authors: Andrea Riccardo Genazzani, Nicola Pluchino, Francesca Bernardi, Manolo Centofanti, Michele Luisi
Published Date October 2006
Volume 2006:2(3) Pages 299 - 307
DOI: http://dx.doi.org/10.2147/NDT.S
Andrea Riccardo Genazzani, Nicola Pluchino, Francesca Bernardi, Manolo Centofanti, Michele Luisi
Department of Reproductive Medicine and Child Development, Division of Obstetrics and Gynecology, University of Pisa, Italy
Abstract: Tibolone is a synthetic molecule used extensively for the management of menopausal symptoms, with the proposed additional advantage of enhanced mood and libido. Tibolone, after oral administration, is rapidly converted into 3 major metabolites: 3α-hydroxy tibolone and 3β-hydroxy tibolone, which have estrogenic effects, and the ∆4-isomer, which has progestogenic and androgenic effects. The tissue-selective effects of tibolone are the result of metabolism, of enzyme regulation, and of receptor activation which vary in different tissues. Tibolone seems to be effective on estrogen-withdrawal symptoms such as hot flushes, sweating, insomnia, headache, and vaginal dryness, with results generally comparable to the effects exerted by estrogen-based treatments, and the additional property of a progestogenic activity on the endometrium. As well as relieving vasomotor symptoms, tibolone has positive effects on sexual well-being and mood, and improves dyspareunia and libido. These effects may depend on both estrogenic and androgenic actions exerted at the genital level and in thecentral nervous system, and on a reduction of sex-hormone-binding globulin and an increase of free testosterone, without affecting ∆-5 androgens levels. Based on the evidence available, tibolone is a valuable treatment option to relieve menopausal complaints, especially in women suffering persistent fatigue, blunted motivation, and loss of sexual desire despite an adequate estrogen replacement.
Keywords: tibolone, menopause, mood, well-being and sexuality
Readers of this article also read:
Increase in IL-6 levels among major depressive disorder patients after a 6-week treatment with duloxetine 60 mg/day: a preliminary observation
Management of achalasia
Cystoid macular edema after cataract surgery in a patient with previous severe iritis following argon laser peripheral iridoplasty
Treatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costs
Influence of habitual physical activity on the symptoms of climacterium/menopause and the quality of life of middle-aged women
Oral contraception and risk of endometrial cancer
Electroencephalography in eating disorders
Estrogen formulations and beauty care practices in Japanese women
Maternal demand for cesarean section: perception and willingness to request by Nigerian antenatal clients
- Have an opinion about one of our articles?
We encourage you to write a Letter to the Editor
- Journal Indexing
See where all the Dove Press journals are indexed
- Testimonials
"... I was impressed at the rapidity of publication from submission to final acceptance." Dr Edwin Thrower, PhD, Yale University
- Long-term treatment of bipolar disorder with a radioelectric asymmetric conveyor
- Implementing the 2009 Institute of Medicine recommendations on resident physician work hours, supervision, and safety
- Moderate alcohol consumption and cognitive risk
- Topiramate in the prevention and treatment of migraine: efficacy, safety and patient preference




